Insider Trading June 11, 2026 06:04 PM

Amprius Technologies Director Dixon Offloads $765K in Shares Amid Stock Volatility and Mixed Earnings

Executive sale coincides with quarterly revenue beat but net loss, as company advances battery partnerships while facing short seller scrutiny.

By Leila Farooq
Share
Twitter Reddit Facebook LinkedIn
AMPX

Amprius Technologies director Donald R. Dixon sold 40,000 shares of common stock on June 9, 2026, realizing proceeds of $765,200 at an average price of $19.13 per share. The transaction occurs against a backdrop of significant price appreciation for AMPX over the past year, alongside recent volatility and mixed fundamental performance. Following the sale, Dixon retains substantial indirect and direct holdings through trusts and partnerships. Concurrently, Amprius reported a first-quarter net loss that missed analyst expectations, though revenue surpassed forecasts. The company is also navigating a collaboration with Matternet for drone battery supply and addressing allegations from short seller Manatee Research regarding operational disclosures.

Amprius Technologies Director Dixon Offloads $765K in Shares Amid Stock Volatility and Mixed Earnings
AMPX
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Director Donald R. Dixon sold 40,000 shares for $765,200, reducing his direct stake while maintaining substantial holdings through trusts and partnerships.
  • Amprius Technologies reported Q1 2026 revenue of $28.5 million, beating forecasts, but incurred a net loss of $5 million, missing earnings expectations.
  • The company is advancing a battery supply partnership with Matternet for drone platforms, targeting volume production readiness by early 2027.

Donald R. Dixon, serving as a director at Amprius Technologies, Inc. (NASDAQ:AMPX), executed a notable transaction on June 9, 2026, by selling 40,000 shares of the company's common stock. The divestment generated a total value of $765,200, with the shares transacted at an average price of $19.13 each. This sale takes place within a complex market environment for AMPX, which has experienced a dramatic surge of over 400% in the preceding twelve months. However, the stock has recently faced heightened volatility, recording a 24% decline over the last week.

Post-transaction, Mr. Dixon maintains a significant stake in Amprius Technologies through several structured entities. He indirectly holds 444,380 shares via The Dixon Revocable Trust, an entity where he and his spouse act as co-trustees. Additionally, he holds an indirect position of 163,142 shares through the Donald & Elizabeth Dixon 2004 Family Partners, where he functions as a co-general partner. Beyond these indirect holdings, Mr. Dixon directly holds 269,656 shares of common stock. According to data derived from InvestingPro analysis, current valuation metrics suggest the stock may be overvalued relative to its Fair Value assessment, especially considering the company's market capitalization stands at $2.37 billion.

Amidst these executive movements, Amprius Technologies released its financial results for the first quarter of 2026. The report indicated a net loss of $5 million, translating to -$0.04 per share. This performance fell short of the anticipated loss of -$0.0278 per share. Despite the earnings miss, the company demonstrated strength in top-line growth, reporting revenue of $28.5 million. This figure exceeded the forecasted revenue of $25.32 million, signaling a divergence between profitability and sales volume expectations.

In strategic developments, Amprius Technologies announced a collaboration with Matternet to supply silicon anode lithium-ion batteries. These power sources are designated for Matternet’s M2 delivery drones. The partnership outlines a broader objective to extend battery solutions to Matternet’s future platforms, with a target readiness for volume production set for early 2027. This initiative highlights the evolving landscape of battery technology supply chains within the logistics and aviation sectors.

Concurrently, Amprius Technologies is addressing allegations raised by short seller Manatee Research. The report, following a month-long investigation, claimed that the company exaggerated orders and exhibited disclosure irregularities. The allegations prompted concerns regarding Amprius’s operations, supported by interviews with battery experts and site visits. These developments have intensified scrutiny from investors and analysts, who are weighing the company's growth trajectory against operational transparency concerns.

Risks

  • Amprius faces allegations from short seller Manatee Research regarding exaggerated orders and disclosure irregularities, raising concerns about operational transparency and investor confidence.
  • The stock has experienced significant volatility, with a 24% decline in the last week despite a 400% surge over the past year, indicating potential pricing instability.
  • Valuation metrics suggest the stock may be overvalued based on Fair Value assessments, posing a risk to future price performance relative to market capitalization.

More from Insider Trading

RA Capital Management Expands Artiva Biotherapeutics Position Amid Clinical Milestones Jun 11, 2026 Nature’s Sunshine Executive Bryant Yates Disposes of $238K in Company Stock Jun 11, 2026 CoreWeave Executive Sells $30.4 Million in Shares Amid Market Volatility Jun 11, 2026 Haas Liquidates $11.86 Million in LEVI Shares Following Class B Conversions Jun 11, 2026 Nexstar CFO Gliha Offloads $132K in Stock Amid Valuation Concerns Jun 11, 2026